ホーム › 肺がん › ミシガン州 › Ann Arbor

Ann Arbor、MIにおける肺がんの臨床試験

Ann Arborとその周辺地域（約30マイル以内）の拠点で、肺がんに関する23件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト（英語）

ここで研究参加者を募集していますか？このページの上部に表示できます — 30日間 $99 →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

被験者募集中第3相

Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Huron Gastroenterology PC, Ypsilanti · 7マイル先
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7マイル先
他4件

18歳以上 · 全性別 · 2026/10/02更新 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

被験者募集中観察研究健康なボランティア歓迎

Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Huron Gastroenterology PC, Ypsilanti · 7マイル先
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7マイル先
他4件

40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

被験者募集中第3相

Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7マイル先
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15マイル先
Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18マイル先

70歳以上 · 全性別 · 2026/10/01更新 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

被験者募集中第3相

Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Huron Gastroenterology PC, Ypsilanti · 7マイル先
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7マイル先
他4件

18歳以上 · 全性別 · 2026/10/01更新 · NCT04181060

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

被験者募集中第3相

University of Michigan Rogel Cancer Center, Ann Arbor
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7マイル先
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15マイル先
他2件

18歳以上 · 全性別 · 2026/10/01更新 · NCT06498635

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

被験者募集中第3相

Trinity Health Ann Arbor Hospital, Ann Arbor

18歳以上 · 全性別 · 2026/09/29更新 · NCT06881784

A Registry for People With Lung Cancer

被験者募集中観察研究

University of Michigan (Data Collection Only), Ann Arbor

18歳以上 · 全性別 · 2026/09/24更新 · NCT06424327

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

被験者募集中第2/3相

Local Institution - 0418, Ann Arbor

18歳以上 · 全性別 · 2026/09/23更新 · NCT07063745

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

被験者募集中第1/2相

University of Michigan Medical School Rogel Cancer Center, Ann Arbor

18歳以上 · 全性別 · 2026/09/21更新 · NCT07629960

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

被験者募集中第3相

University of Michigan, Ann Arbor

18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

被験者募集中第3相

University of Michigan, Ann Arbor

18歳以上 · 全性別 · 2026/08/19更新 · NCT07499674

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

被験者募集中第3相

Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7マイル先
Chelsea Hospital, Chelsea · 15マイル先
他3件

18歳以上 · 全性別 · 2026/08/17更新 · NCT05624996

Gilteritinib for the Treatment of ALK NSCLC

被験者募集中第1相

University of Michigan Comprehensive Cancer Center, Ann Arbor

18歳以上 · 全性別 · 2026/06/26更新 · NCT06225427

Prediction Augmented Screening Initiative

被験者募集中

VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor

50歳〜80歳 · 全性別 · 2026/06/26更新 · NCT06538636

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

被験者募集中第2相

Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Huron Gastroenterology PC, Ypsilanti · 7マイル先
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7マイル先
他4件

18歳以上 · 全性別 · 2026/06/03更新 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

被験者募集中第2相

Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Huron Gastroenterology PC, Ypsilanti · 7マイル先
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7マイル先
他4件

18 Minutes · 全性別 · 2026/05/05更新 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

被験者募集中第2/3相

Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7マイル先
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15マイル先
Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18マイル先

18歳以上 · 全性別 · 2026/05/05更新 · NCT06616584